Construction of fluorescent transgenic zebrafish Tg (ttn.2: EGFP) / 生物工程学报

In order to develop a transgenic zebrafish line with green fluorescent protein (enhanced green fluorescent protein, EGFP) expressed specifically in muscle and heart, the recombinant expression vector constructed using the zebrafish ttn.2 gene promoter fragment and EGFP gene coding sequence and the capped mRNA of Tol2 transposase were co-injected into the zebrafish 1-cell stage embryos. The stable genetic Tg (ttn.2: EGFP) transgenic zebrafish line was successfully developed by fluorescence detection, followed by genetic hybridization screening and molecular identification. Fluorescence signals and whole-mount in situ hybridization showed that EGFP expression was located in muscle and heart, the specificity of which was consistent with the expression of ttn.2 mRNA. Inverse PCR showed that EGFP was integrated into chromosomes 4 and 11 of zebrafish in No. 33 transgenic line, while integrated into chromosome 1 in No. 34 transgenic line. The successful construction of this fluorescent transgenic zebrafish line, Tg (ttn.2: EGFP), laid a foundation for the research of muscle and heart development and related diseases. In addition, the transgenic zebrafish lines with strong green fluorescence can also be used as a new ornamental fish.

Genetically modified organisms: adapting regulatory frameworks for evolving genome editing technologies

Genetic modification of living organisms has been a prosperous activity for research and development of agricultural, industrial and biomedical applications. Three decades have passed since the first genetically modified products, obtained by transgenesis, become available to the market. The regulatory frameworks across the world have not been able to keep up to date with new technologies, monitoring and safety concerns. New genome editing techniques are opening new avenues to genetic modification development and uses, putting pressure on these frameworks. Here we discuss the implications of definitions of living/genetically modified organisms, the evolving genome editing tools to obtain them and how the regulatory frameworks around the world have taken these technologies into account, with a focus on agricultural crops. Finally, we expand this review beyond commercial crops to address living modified organism uses in food industry, biomedical applications and climate change-oriented solutions.

Chromatographic determination of shikimate for identification of conventional soybean and glyphosate resistant soybean / Determinação cromatográfica de shikimato para identificação de soja convencional e soja resistente ao glifosato

A sensitive and reliable process was established using high-performance liquid chromatography (HPLC) to distinguish conventional varieties of glyphosate-resistant genetically modified crops via shikimate detection in soybean (Glycine max L. Merril) seeds. Glyphosate has a well-defined mechanism of action. It is the only herbicide that specifically inhibits 5-enolpiruvilshikimate-3-phosphate synthase (EPSPS E.C. 2.5.1.19), which catalyzes the condensation of shikimate with phosphoenolpyruvate. This study is based on the concept that shikimate significantly accumulates in soybean plant tissues after EPSPS inhibition by glyphosate. In plants not subjected to glyphosate, shikimate is not easily detected because it quickly metabolizes into shikimate 3-phosphate and subsequently into 5-enolpiruvilshikimate 3-phosphate through the action of EPSPS. Conversely, in non-genetically modified plants subjected to glyphosate, shikimate metabolism is impaired, resulting in its accumulation. This metabolite can be detected in extremely low quantities (in the microgram range), through HPLC. In this study, six different contrasts were analyzed, each being formed by a transgenic cultivation and its parental strain, subject or not subject to the treatment of soaking with a 0.6% glyphosate solution. Chromatographic analyses indicated shikimate accumulation only in conventional cultivars with seeds previously soaked in a 0.6% glyphosate solution. Thus, this shikimate detection method can be used as a rapid and accurate means to distinguish soybeans with glyphosate-resistant qualities.

Este estudo estabelece um processo, sensível e confiável, com aplicação de cromatografia líquida de alta eficiência (HPLC) para distinguir variedades de soja convencionais de geneticamente modificadas, resistentes ao glifosato, por detecção de chiquimato nas sementes. O mecanismo de ação doglifosato é bem definido. É o único herbicida que inibe especificamente a enzima 5-enolpiruvilchiquimato-3-fosfato sintase (EPSPS, E.C. 2.5.1.19), que catalisa a condensação do chiquimato com fosfoenolpiruvato. O trabalho está baseado na concepção do chiquimato se acumular significativamente nos tecidos vegetais de soja convencional, após a inibição da EPSP sintase pelo glifosato. Em plantas não submetidas ao glifosato, o chiquimato não é facilmente detectado, pois rapidamente é metabolizado a chiquimato 3-fosfato e, a seguir, em 5-enolpiruvilchiquimato 3-fosfato, pela ação da EPSPS. Por outro lado, em plantas não geneticamente modificadas submetidas ao glifosato, a metabolização do chiquimato é prejudicada, resultando em seu acúmulo. Este metabólito pode ser detectado em quantidades extremamente baixas (na faixa de µg), por HPLC. Neste trabalho foram analisados seis contrastes diferentes, sendo cada contraste formado por uma cultivar transgênica e sua respectiva cultivar parental convencional, submetidas ou não a embebição com solução de glifosato 0,6%. As análises cromatográficas indicaram o acúmulo de chiquimato apenas em cultivares convencionais, nas quais as sementes foram previamente embebidas em solução de glifosato 0,6%. Os resultados demonstraram que adetecção de chiquimato pode ser utilizada como um método rápido e preciso na diferenciação de soja resistente ao glifosato de soja convencional.

Simplified methodology for large scale isolation of homozygous transgenic lines of lettuce

Background: Lettuce is a globally important leafy vegetable and a model plant for biotechnology due to its adaptability to tissue culture and stable genetic transformation. Lettuce is also crucial for functional genomics research in the Asteraceae which includes species of great agronomical importance. The development of transgenic events implies the production of a large number of shoots that must be differentiated between transgenic and non-transgenic through the activity of the selective agent, being kanamycin the most popular. Results: In this work we adjusted the selection conditions of transgenic seedlings to avoid any escapes, finding that threshold concentration of kanamycin was 75 mg/L. To monitor the selection system, we studied the morphological response of transgenic and non-transgenic seedlings in presence of kanamycin to look for a visual morphological marker. Several traits like shoot length, primary root length, number of leaves, fresh weight, and appearance of the aerial part and development of lateral roots were affected in non-transgenic seedlings after 30 d of culture in selective media. However, only lateral root development showed an early, qualitative and reliable association with nptII presence, as corroborated by PCR detection. Applied in successive transgenic progenies, this method of selection combined with morphological follow-up allowed selecting the homozygous presence of nptII gene in 100% of the analyzed plants from T2 to T5. Conclusions: This protocol allows a simplified scaling-up of the production of multiple homozygous transgenic progeny lines in the early generations avoiding expensive and time-consuming molecular assays.

DISEÑO DE CASETES DE EXPRESIÓN QUE CONFIERAN TOLERANCIA A SEQUÍA Y A GLUFOSINATO EN MAÍZ (Zea mays) / Design of Expression Cassettes that Confer Drought and Glufosinate Tolerance to Maize (Zea mays)

Como primera aproximación en la obtención de una línea transgénica de maíz tolerante a sequía y al herbicida glufosinato de amonio, se seleccionaron genes y elementos reguladores para el diseño in silico de casetes de expresión, a través del análisis de literatura científica y bases de datos de genes y patentes. Las secuencias génicas fueron modificadas con base en el criterio de uso codónico del maíz para optimizar su expresión. Los casetes de expresión diseñados con el software DNA 2.0., fueron sintetizados por una empresa especializada. La presencia del transgen y la expresión a nivel de mARN fue demostrada mediante PCR y RT-PCR en la planta modelo Nicotiana benthamiana transformada vía Agrobacterium tumefaciens. Un ensayo preliminar in vitro en condiciones simuladas de sequía en medio MS con PEG (PM 6000)10 % no demostró incremento notorio en la tolerancia de las plántulas transformantes, posiblemente debido a que el uso codónico del diseño no favorece la expresión génica en la planta modelo.

As a first approach in obtaining a transgenic drought and glufosinate ammonium tolerant maize line, genes and regulatory elements for the in silico design of the expression cassettes were selected through analysis of scientific literature and databases of genes and patents. Gene sequences were modified based on the criterion of maize codon usage to optimize their expression. The constructs designed with DNA 2.0 Software, were synthesized by a specialized company. The presence of the transgene and the expression of mRNA was demonstrated by PCR and RT-PCR in the model plant Nicotiana benthamiana transformed via Agrobacterium tumefaciens. A preliminary experiment in vitro under simulated drought conditions in MS medium with 10 % PEG (PM 6000) showed no noticeable increase in drought tolerance of the transformants, possibly because the codon usage of the design does not promote gene expression in the model plant.

Transgenesis for pig models

Animal models, particularly pigs, have come to play an important role in translational biomedical research. There have been many pig models with genetically modifications via somatic cell nuclear transfer (SCNT). However, because most transgenic pigs have been produced by random integration to date, the necessity for more exact gene-mutated models using recombinase based conditional gene expression like mice has been raised. Currently, advanced genome-editing technologies enable us to generate specific gene-deleted and -inserted pig models. In the future, the development of pig models with gene editing technologies could be a valuable resource for biomedical research.

Damage caused by Dichelops melacanthus (Heteroptera: pentatomidae) in conventional and transgenic corn hybrids / Danos ocasionados por Dichelops melacanthus (Heteroptera: pentatomidae) em híbridos convencionais e transgênicos de milho

This study evaluated the symptoms of attack by the green belly stink bug, Dichelops melacanthus (Dallas, 1851), in conventional and transgenic commercial corn (Zea mays) hybrids, the seeds of which were either treated using the insecticide thiamethoxam or without chemical treatment. The experiment was conducted during the 2010/2011 crop season in Pindorama, São Paulo State, Brazil. The percentage of plants with symptoms or injuries was recorded by visually evaluating the degree or intensity of attack symptoms. The height of the plants was also recorded on a weekly basis, until the plants were 40 DAE. We also measured yield compounds, such as the number of rows of grain/spikes, spike weight (with and without straw), and grain weight. The seeds of hybrids that had previously been treated with thiamethoxam showed lower percentage of the number of plants that were attacked. Further, the grain weight of the plants increased 29.5% more than that of plants from untreated seeds. It was also found that transgenic hybrids exhibited lower height reduction in 40 DAE plants than did conventional isolines. Visual inspection is effective in assessing the degree of injury caused by attacks to the developing plants.

Este trabalho teve como objetivos avaliar os sintomas de ataque de D. melacanthus e seus respectivos danos, ocasionados em diferentes híbridos comerciais convencionais e transgênicos, submetidos ou não ao tratamento químico de sementes. O experimento foi realizado no ano agrícola de 2010/2011, em área experimental da APTA, Polo Regional Centro Norte, localizado em Pindorama, SP. Os parâmetros avaliados foram a porcentagem de plantas com sintomas ou injúrias de ataque, avaliando-se o grau ou intensidade de sintomas de ataque nas plantas, através de uma escala visual de notas de danos. A altura das plantas foi avaliada semanalmente até os 40 dias de idade das plantas (DAE). Avaliou-se as características de produtividade como o número de fileiras de grãos/espiga, peso (g) de espiga com e sem palha, e peso de grãos (g). Verificou-se que híbridos cujas sementes foram tratadas previamente com inseticida sistêmico thiametoxam, apresentaram menor porcentagem de plantas atacadas, maior desenvolvimento e aumento de 29,5% no peso de grãos em comparação às plantas oriundas de sementes não tratadas. Verificou-se também que os híbridos transgênicos apresentaram menor redução da altura aos 40 DAE, do que as suas isolinhas convencionais. A escala visual de notas foi eficiente para avaliar o grau de sintomas ou injúrias causadas pelo ataque da praga às plantas em desenvolvimento.

Comparison of different methods for exogenous DNA uptake by bovine spermatozoa / Comparação de diferentes métodos de incorporação de DNA exógeno pelo espermatozoide bovino

Although genetic manipulation of farm animals is of great interest for animal production and the pharmaceutical industry, its efficiency remains far from satisfactory. Pronuclear injection, which is the most widely used technique for such modification, mainly in mice, remains limited for this species. Some alternatives have been developed such as sperm mediated gene transfer, in which the spermatozoa are used as vectors for DNA delivery during in vitro fertilization. Mature sperm cells are able to spontaneously bind exogenous DNA molecules which may be internalized into sperm nuclei. Given the potential of sperm mediated gene transfer for livestock animals transgenesis, the aim of this study was to evaluate four methods of DNA uptake for sperm mediated gene transfer in bovine: incubation with DNA, plasma membrane alteration induced by calcium ionophore followed by incubation with DNA, electroporation and lipofection. Spermatozoa not exposed to exogenous DNA were used as control group. Cleavage, blastocyst and hatching rates were recorded at 72 hours post insemination (hpi), days 9 and 12 of embryo culture, respectively. Exogenous DNA-positive embryos were evaluated by PCR. No effect of treatment was observed on cleavage, blastocyst and hatching rates. In addition, percentage of DNA positive blastocysts did not differ among experimental groups. In spite of the low number of positive embryos, our results show that all treatments presented similar efficiencies for DNA delivery during in vitro fertilization. In conclusion, although the development rates were similar and constant in all groups, other factors such as exogenous DNA sequence, size and concentration should be considered to improve sperm mediated gene transfer.

Apesar da manipulação genética de animais domésticos ser de grande interesse para a produção animal e para a indústria farmacêutica, a sua eficiência ainda é insatisfatória. A injeção pronuclear, a técnica mais utilizada para tal propósito, principalmente em camundongos, ainda apresenta limitações para esta espécie. Algumas alternativas têm sido desenvolvidas como o uso de espermatozoides como vetores para transferência gênica, na qual a célula espermática tem habilidade espontânea de se ligar à molécula de DNA e internalizá-la. Dado o potencial da transferência gênica mediada por espermatozoide para animais domésticos transgênicos, o objetivo do presente trabalho foi a avaliação de quatro métodos de incorporação de DNA para a transferência gênica mediada por espermatozoides na espécie bovina: incubação com DNA, alteração da membrana plasmática induzida por cálcio ionóforo seguida por incubação com o DNA exógeno, eletroporação e lipofecção. Espermatozoides não expostos ao DNA exógeno foram usados como grupo controle. Os índices de clivagem, blastocisto e eclosão foram avaliados, respectivamente, as 72 horas após a inseminação dos oócitos, bem como, aos 9 e 12 dias de cultivo embrionário. Os embriões positivos para o DNA exógeno foram avaliados por PCR. Nenhum efeito de tratamento foi observado nos índices de clivagem, blastocisto e eclosão. Além disso, a porcentagem de blastocistos positivos para o DNA exógeno não diferiu entre os grupos experimentais. Apesar do baixo número de embriões positivos para DNA exógeno, os resultados obtidos mostram que todos os tratamentos apresentaram eficiências similares. A conclusão obtida foi que, apesar de os índices de desenvolvimento embrionário terem sido similares e constante em todos os grupos experimentais, outros fatores como a sequência, o tamanho e a concentração do DNA exógeno devem ser avaliados para melhorar a transferência gênica mediada por espermatozoides.

Ultrasonographic evaluation of hG-CSF transgenic goat conceptus / Avaliação ultrassonográfica de conceptos transgênicos para o hG-CSF

The objective of this study was to evaluate the development of transgenic (T) goat embryos and fetuses for human Granulocyte Colony Stimulating Factor (hG-CSF) by ultrasonography. Four pregnancies in non-transgenic (NT) goats were obtained after fertilization (either fixed-time artificial insemination or natural mating) using the T male for hG-CSF. Ultrasound examinations were carried out at 30, 40 (transrectal via), 50, 60, 90 and 120 days of pregnancy (transabdominal via). Some parameters were observed such as morphology, organogenesis and formation of skeletal fetuses, viability with cardiac activity and fetuses movements. Measurements were taken of the crown-rump length, diameter of embryonic vesicle, thorax, abdomen, umbilical cord and placentomes. After parturition, DNA testing was conducted in all offspring and 4 T and 2 NT kids were identified. The conceptus started their differentiation at 40 days. The heart was detected in all examinations and the heart chambers were assessed at 50 days. Gastric compartments, liver and kidneys were observed at 60 days, the same period that all bony structures were visualized. Average values of all evaluated parameters had a gradual increase with the progression of pregnancy. T and NT goat embryos and fetuses had a similar growth and all remained viable throughout the experimental period.

O objetivo deste estudo foi avaliar o desenvolvimento de embriões e fetos transgênicos (T) para o Fator Estimulante de Colôniasde Granulócitos humano (hG-CSF) por ultrassonografia. Quatro gestações em cabras não transgênicas (NT) foram obtidas pos fecundação (inseminação artificial em tempo fixo ou monta controlada) utilizando o bode T para o hG-CSF. Exames ultrassonográficos foram realizados aos 30, 40 (via transretal), 50, 60, 90 e 120 dias de gestação (via transabdominal). Alguns parâmetros foram observados como morfologia, organogênese e formação do esqueleto fetal, viabilidade por meio de atividade cardíaca e movimento fetal. As seguintes mensurações foram realizadas: comprimento crânio caudal, diâmetro da vesícula embrionária, do tórax, do abdomen, do cordão umbilical e dos placentomas. Após o parto, o exame por PCR foi conduzido em todas as crias e 4 T e 2NT foram identificadas. O concepto iniciou sua diferenciação aos 40 dias. O coração foi detectado em todos os exames e as câmeras cardíacas foram identificadas aos 50 dias. Compartimentos gástricos, fígado e rins foram observados aos 60 dias, o mesmo período que todas as estruturas ósseas foram visualizadas. Valores médios de todos os parâmetros avaliados tiveram um aumento gradual com o avanço da gestação. Embriões e fetos T e NT tiveram um crescimento similar e todos permaneceram viáveis durante o período experimental.

Genetically Engineered Mouse Models for Drug Development and Preclinical Trials

Drug development and preclinical trials are challenging processes and more than 80% to 90% of drug candidates fail to gain approval from the United States Food and Drug Administration. Predictive and efficient tools are required to discover high quality targets and increase the probability of success in the process of new drug development. One such solution to the challenges faced in the development of new drugs and combination therapies is the use of low-cost and experimentally manageable in vivo animal models. Since the 1980's, scientists have been able to genetically modify the mouse genome by removing or replacing a specific gene, which has improved the identification and validation of target genes of interest. Now genetically engineered mouse models (GEMMs) are widely used and have proved to be a powerful tool in drug discovery processes. This review particularly covers recent fascinating technologies for drug discovery and preclinical trials, targeted transgenesis and RNAi mouse, including application and combination of inducible system. Improvements in technologies and the development of new GEMMs are expected to guide future applications of these models to drug discovery and preclinical trials.

Mensurações ultrassonográficas da cisterna da glândula mamária de caprino transgênico / Ultrasound measurements of the mammary gland of transgenic hormone-induced lactating goat

Milk production of transgenic does was evaluated by ultrasound measurements of the mammary gland. Two Canindé goats, which were nine months of age were used in the trial, one non-transgenic or other transgenic for hG-CSF. For hormone-induced lactation, animals were given estradiol (0.25mg/kg, IM), progesterone (0.75mg/kg, IM), and prednisolone (0.4mg/kg, IM). Ultrasonographic exams were carried out during milking, using a Falcon 100 ultrasound equipment with a 5MHz convex probe and were performed by the same operator. The results were expressed as mean±standard error. The maximum greater length and shorter length of the cistern were respectively 5.14cm and 1.36cm for the transgenic animal and 7.28cm and 2.25cm for non-transgenic, which is consistent with the maximum milk volume produced. The relationship between the average area of cisterns and milk yield was expressed as a linear correlation curve, with a correlation coefficient significantly positive for both transgenic (Y=-1.1314+10.8538*x; r=0.97) and non-transgenic (Y=-21.7551+18.3634*x; r=0.97) animals. In conclusion, the ultrasound is a practice and appropriate technique to evaluate the cisterns in ruminant udders in transgenic animal.

Progress with schistosome transgenesis

Genome sequences for Schistosoma japonicum and Schistosoma mansoni are now available. The schistosome genome encodes ~13,000 protein encoding genes for which the function of only a minority is understood. There is a valuable role for transgenesis in functional genomic investigations of these new schistosome gene sequences. In gain-of-function approaches, transgenesis can lead to integration of transgenes into the schistosome genome which can facilitate insertional mutagenesis screens. By contrast, transgene driven, vector-based RNA interference (RNAi) offers powerful loss-of-function manipulations. Our laboratory has focused on development of tools to facilitate schistosome transgenesis. We have investigated the utility of retroviruses and transposons to transduce schistosomes. Vesicular stomatitis virus glycoprotein (VSVG) pseudotyped murine leukemia virus (MLV) can transduce developmental stages of S. mansoni including eggs. We have also observed that the piggyBac transposon is transpositionally active in schistosomes. Approaches with both VSVG-MLV and piggyBac have resulted in somatic transgenesis and have lead to integration of active reporter transgenes into schistosome chromosomes. These findings provided the first reports of integration of reporter transgenes into schistosome chromosomes. Experience with these systems is reviewed herewith, along with findings with transgene mediated RNAi and germ line transgenesis, in addition to pioneering and earlier reports of gene manipulation for schistosomes.

Production of recombinant proteins in milk of transgenic and non-transgenic goats

Among all the transgenic mammalians produced so far, goats have represented an excellent model of transgenesis when considering the factors such as the market demand for protein, volume of milk produced per lactation and reproductive rate. Various recombinant proteins have been obtained from the transgenic and non-transgenic goats, and among these, human antithrombin, produced by the transgenic goats, was the first recombinant protein of animal origin to be released as a drug for the clinical use in humans. This review reports the aspects inherent to the production of recombinant proteins in the goats, from the production of the animal bioreactors up to the expression of these proteins in their milk.

Testis-mediated gene transfer in mice: comparison of transfection reagents regarding transgene transmission and testicular damage

Testis-mediated gene transfer (TMGT) has been used as in vivo gene transfer technology to introduce foreign DNA directly into testes, allowing mass gene transfer to offspring via mating. In this study, we used plasmid DNA (pEGFP-N1) mixed with dimethylsulfoxide (DMSO), N,N-dimethylacetamide (DMA) or liposome (Lipofectin) in an attempt to improve TMGT. Males receiving consecutive DNA complex injections were mated to normal females to obtain F0 progeny. In vivo evaluation of EGFP expression, RT-PCR and PCR were used to detect the expression and the presence of exogenous DNA in the progeny. We also evaluated possible testicular damage by histological procedures. PC R and RT-PCR analyses revealed that liposome and DMSO increased the rate of TMGT. Histological analyses demonstrated that repeated (4 times) injections of DNA complexes can affect spermatogenesis. DMSO was the most deleterious among the reagents tested. In this study, we detected the presence of transgene in the progeny, and its expression in blood cells. Consecutive injections of DNA complexes were associated with impaired spermatogenesis, suggesting requirement of optimal conditions for DNA delivery through TMGT.

Transgénesis mediada por espermatozoides en la especie porcina: efecto de la presencia de ADN exógeno sobre la calidad seminal y evaluación de la producción in vivo de embriones transgénicos / Sperm mediated gene transfer in pigs: Effect of exogenous DNA presence in seminal quality and evaluation of in vivo transgenic embryo production

Una alternativa biotecnológica para la producción de animales transgénicos es la transgénesis mediada por espermatozoides (SMGT), basada en la habilidad de las células espermáticas de unir e interiorizar ADN exógeno. En este estudio se plantearon dos objetivos principales: 1) evaluar el efecto de la presencia de ADN exógeno sobre la calidad seminal y 2) evaluar la eficiencia en la producción de embriones transgénicos porcinos in vivo mediante inseminación intrauterina quirúrgica con espermatozoides incubados con el transgén. Para alcanzar estos objetivos, los espermatozoides (libres de plasma seminal) fueron incubados en presencia del transgén EGFP (proteína verde fluorescente) durante 2 h a 16°C (en una relación de 10(8) cels/mL y 5 µg ADN/mL). Se valoró la motilidad, motilidad progresiva e integridad de membrana de los espermatozoides incubados, en presencia o ausencia del transgén. Los resultados mostraron que la presencia del ADN no afectó a ninguno de los parámetros seminales estudiados. Con muestras seminales incubadas con el transgén se llevaron a cabo inseminaciones intrauterinas mediante laparotomía en 4 hembras prepúberes. A los 6-7 días tras la inseminación se recolectaron los embriones, para evaluar la tasa de fecundación y la expresión de la proteína verde fluorescente EGFP en los mismos. El número medio de cuerpos lúteos por cerda fue de 10,50 ± 2,90 con una tasa de recolección de 11,90%. Se recolectó un total de 5 embriones presentando todos ellos un estado normal de desarrollo y una alta calidad (dos de ellos presentaban más de 400 células por embrión). Cuando fue analizada la expresión mediante microscopia de fluorescencia, ninguno de ellos expresaba la proteína EGFP. Este resultado, bajo las condiciones experimentales del presente estudio, podría indicar que el transgén se una en su mayoría a espermatozoides con baja viabilidad por lo que la probabilidad de que los espermatozoides vivos unan el ADN y sean capaces de fecundar en comparación con espermatozoides sin el transgén es realmente baja.

An alternative technology for producing transgenic animals is sperm mediated gene transfer (SMGT), based on the ability of sperm cells to bind and internalize exogenous DNA. The aims of this work were: 1) evaluate the effects of the presence of exogenous DNA in the seminal quality and 2) evaluate the efficiency of transgenic embryos production by surgery artificial insemination using sperm mediated gene transfer technique. Fresh spermatozoa (removed seminal plasma) were incubated with DNA (EGFP) at 16°C for 2 h (10(8) cells/mL and 5 µg DNA/mL). At first motility, progressive motility and viability were evaluated in spermatozoa incubated with or without exogenous DNA. The results showed that the presence of the DNA did not affect any of the studied sperm parameters (motility, progressive motility and viability). On the other hand insemination was carried out in 4 gilts by laparotomy in utero tubaric junction. Six-seven days after insemination blastocysts were collected and fertilization rate and transgene expression were determined. The mean number of corpora lutea/gilt was 10.50 ± 2.90 with a mean recovery rate of 11.90%. After the surgery, a total of 5 embryos were recovered and the percentage of normally developed embryos was 100% and with a high quality (two of them had more than 400 cells). When the blastocysts recovered after 6-7 days post-insemination were analyzed by fluorescence microscopy, it was revealed that none of them expressed protein EGFP. These results show the possibility that exogenous DNA bound to the sperm with low viability and only a low percentage to viable sperm, so the probability that live sperm bind the DNA and are able to fertilize in comparison with live sperm without the transgene are really low.

Production of transgenic goat (Capra hircus) with human Granulocyte Colony Stimulating Factor (hG-CSF) gene in Brazil

In order to produce transgenic goats with hG-CSF, a total of 24 adult Saanen and 48 adult undefined breed goats were used as donors and recipients, respectively. Donors were estrus-synchronized with vaginal sponges and superovulated by a treatment with 200 mg FSH given twice daily in decreasing doses over 3 days starting 48 h before sponge removal. Ovulation was induced by injecting 100µg GnRH 36 h after sponge removal. The recipients also received an estrus synchronization treatment. Donors were mated with fertile Saanen bucks and, approximately 72 h after sponge removal, zygotes were recovered surgically by flushing oviducts. The recovered zygotes were briefly centrifuged to a reliable visualization of the pronuclei. The DNA construct containing hG-CSF gene flanked by goat and bovine alphas1-casein sequences was injected into pronuclei of 129 zygotes. The microinjected embryos (3-6 per female) were transferred to 27 recipients. Ten recipients became pregnant and 12 kids were born. One transgenic male founder was identified in the group of kids. This is the first report of a birth of a transgenic goat in Latin America.

A fim de produzir caprinos transgênicos para o hG-CSF, utilizou-se 24 cabras Saanen adultas e 48 cabras sem raça definida adultas como doadoras e receptoras, respectivamente. As doadoras tiveram o estro sincronizado por esponjas vaginais e foram superovuladas com 200 mg de FSH em doses decrescentes, duas vezes ao dia e iniciando 48 h antes da retirada da esponja. A ovulação foi induzida pela injeção de 100 µg de GnRH às 36 h após a retirada da esponja. As receptoras também receberam um tratamento de sincronização do estro. As doadoras foram cobertas por bodes Saanen férteis e, aproximadamente 72 h após a retirada da esponja, os zigotos foram colhidos cirurgicamente por lavagem dos ovidutos. Os zigotos colhidos foram rapidamente centrifugados para uma melhor visualização dos pró-núcleos. A construção de DNA, contendo o gene do hG-CSF flanqueado pelos genes caprino e bovino da alfas1-caseína, foi injetada em 129 embriões. Os embriões microinjetados (3 a 6 por receptora) foram transferidos para 27 receptoras que responderam ao tratamento. Dez receptoras ficaram gestantes e 12 crias foram produzidas. Um macho transgênico fundador foi identificado no grupo de crias nascidas. Este é o primeiro relato do nascimento de um caprino transgênico na América Latina.

Blood Pressure Regulation by Vasoactive Peptide Genes: Transgenic And Knockout Animal Models

Hypertension is a polygenic and multifactorial disease and is intimately related to salt homeostasis. Four important vasoactive peptide systems participate in regulating blood pressure and salt homeostasis. Their interplay is indispensible in many physiologic and pathologic conditions. While the renin-angiotensin and the endothelin systems raise blood pressure by inducing vasoconstriction and sodium retention (or excretion), the kallikrein-kinin and the natriuretic peptide systems reduce blood pressure by eliciting vasodilatation and natriuresis. Gene targeting as well as transgenesis have provided us a lot of information on the biological functions of the genes of these systems. Animal models from these technologies are discussed in relation to blood pressure regulation.

Transgenic mosquitoes for malaria control: progresses and challenges / Mosquitos transgênicos para o controle da malária: progressos e desafios

Malaria kills millions of people every year and the current strategies to control the disease, such as insecticides and drugs have not been completely efficient. Because of that, novel means to fight against malaria are of utmost importance. Advances in the study of the mosquito vector and its interactions with the malaria parasite made scientists think that it is possible to genetically manipulate the mosquitoes to make them inefficient vectors. Here we review the advances on the introduction of foreign genes into the mosquito germ line, the characterization of tissue-specific promoters, the identification of gene products that block development of the parasite in the mosquito, and we discuss the recent generation of transgenic mosquitoes impaired for malaria transmission. While much progress has been made, many years of research are still needed before transgenic mosquitoes can be used in the field.

A malária mata milhões de pessoas a cada ano e as estratégias atuais de controle da doença, como inseticidas e drogas não têm sido tão eficientes. Por este motivo, novos meios para o combate à malária são de extrema importância. Avanços no estudo do mosquito vetor e sua interação com o parasito da malária fizeram os cientistas pensarem que é possível a manipulação genética dos mosquitos para torná-los vetores ineficientes. Neste artigo, revisamos os avanços na introdução de genes exógenos na linhagem germinativa de mosquitos, a caracterização de promotores específicos de certos tecidos, a identificação de produtos gênicos que bloqueiam o parasita no mosquito, bem como discutimos a recente geração de mosquitos transgênicos, menos eficientes na transmissão de malária. Enquanto muitos progressos foram obtidos, muitos anos de pesquisa são ainda necessários para que mosquitos transgênicos possam ser utilizados na natureza.

Isolation of Mouse Ig Heavy and Light Chain Genomic DNA Clones, and Construction of Gene Knockout Vector for the Generation of Humanized Xenomouse

BACKGROUND: Monoclonal antibodies (mAb) of rodent origin are produced with ease by hybridoma fusion technique, and have been successfully used as therapeutic reagents for humans after humanization by genetic engineering. However, utilization of these antibodies for therapeutic purpose has been limited by the fact that they act as immunogens in human body causing undesired side effects. So far, there have been several attempts to produce human mAbs for effective in vivo diagnostic or therapeutic reagents including the use of humanized xenomouse that is generated by mating knockout mice which lost Ig heavy and light chain genes by homologous recombination and transgenic mice having both human Ig heavy and light gene loci in their genome. METHODS: Genomic DNA fragments of mouse Ig heavy and light chain were obtained from a mouse brain lamda genomic library by PCR screening and cloned into a targeting vector with ultimate goal of generating Ig knockout mouse. RESULTS: Through PCR screening of the genomic library, three heavy chain and three light chain Ig gene fragments were identified, and restriction map of one of the heavy chain gene fragments was determined. Then heavy chain Ig gene fragments were subcloned into a targeting vector. The resulting construct was introduced into embryonic stem cells. Antibiotic selection of transfected cells is under the progress. CONCLUSION: Generation of xenomouse is particularly important in medical biotechnology. However, this goal is not easily achieved due to the technical difficulties as well as huge financial expenses. Although we are in the early stage of a long-term project, our results, at least, partially contribute the successful generation of humanized xenomouse in Korea.